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Tracheobronchopathia osteochondroplastica (TO) is a rare disorder of unknown
cause that affects the tracheobronchial tree. It is characterized by the presence of
multiple osseous and/or cartilaginous submucosal nodules protruding into the
lumen of the trachea and large bronchi, which typically spares the posterior wall.
1,2
Amyloidosis is an uncommon disease, in which various organs are infiltrated by
amorphous extracellular eosinophilic material, composed of insoluble proteins
that have a high degree of beta-pleated sheet protein structure.
3 TO can especially
show asthma like symptoms.
1
We describe a case that was initially thought to be asthma bronchiole but was
later diagnosed as TO and tracheobronchial amyloidosis. 
A 53-year-old man had a history of chronic cough and wheezing, recurrent lower
respiratory tract infections, and progressive shortness of breath. Asthma had been
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Tracheobronchopathia osteochondroplastica (TO) is a rare disorder of unknown cause characterized by the
presence of multiple submucosal osseous and/or cartilaginous nodules that protrude into the lumen of the trachea
and large bronchi. A simultaneous diagnosis of TO and amyloidosis is rarely reported. In this report, a case initially
suspected to be asthma bronchiole that could not be treated, was radiologically diagnosed as TO, and also
secondary amyloidosis is presented. A 53 years, man patient reported a 3 years history of dyspnea. Pulmonary
function tests (PFTs) showed an obstructive pattern. Chest X-rays revealed right middle lobe atelectasis. FOB and
CT detected nodular lesions in the trachea and in the anterior and lateral walls of the main bronchi. AA amyloidosis
was confirmed by endobronchial biopsy. In the abdominal fat pad biopsy, amyloidosis was not detected. Asthma
bronchiole was excluded by PFTs. This case illustrates that it is possible for TO and amyloidosis to masquerade as
asthma. TO and amyloidosis should be suspected in patients of older ages with asthma and especially with poorly
treated asthmatic patients. Although nodular lesions in the anterior and lateral tracheobronchial walls are typical for
TO, a biopsy should be obtained to exclude amyloidosis.
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INTRODUCTION
CASE REPORTmisdiagnosed in the previous 3 years of this patient, and
his therapy included an inhaled beta-adrenergic agonist
and glucocorticoid. He denied coughing, stridor, and
hemoptysis. His medical history was not significant for
tobacco abuse.
On admission, his temperature was 36.9˚C, pulse rate
was 89 beats/min, respiratory rate was 19 breaths/min, and
BP was 135/85 mm Hg. Auscultation of his lungs revealed
diffuse rhonchi, and palpation revealed no abdominal
organomegaly. The results from the examination of the
centural nervous system (CNS) and skin were normal.
Furthermore, physical examination of oral cavity and
oropharynx was normal.
The results of his blood, chemistry, liver function, urine
tests including creatinine clearance rate, urinalysis for
urinary protein, beta-2 microglobulin, and serum immu-
noglobulin levels, renal ultrasonography, echocardiography,
and electrocardiography were normal. Assays for human
immunodeficiency virus and antineutrophil cytoplasmic
antibodies were negative, and his rapid plasma reagin was
nonreactive. Pulmonary function tests were indicative of an
obstructive airway disease [Forced Vital Capacity (FVC):
49% of predicted, Forced Expiratory Volume (FEV)  1: 43%
of predicted and FEV1/FVC: 68% of predicted], and the
reversibility test was found to be negative.
The chest radiograph at admission showed homogenous
opacity in the right middle lobe which is consistent with
the symptoms of atelectasia.
Computed tomography showed the prominent cartilag-
inous nodules protruding into the airway lumen. Other
roentgenologic findings include the thickening or irregul-
arity of the tracheal and/or bronchial walls with sparing of
the membranous posterior wall, deformed tracheal cartilage
rings without evidence of external compression or submu-
cosal calcification, and atelectasis of the right middle lobe
(Fig. 1).
Fiberoptic bronchoscopic examination revealed mucosal
nodules protruding into the lumen of the trachea (Fig. 2).
These lesions extended throughout the trachea but
extended especially in the middle and lower thirds; nodules
were also present in the carina and in the medial wall of
the two main bronchi. The posterior walls of the trachea and
main bronchi were characteristically not involved. The
lumen of the right middle lobe bronchus was completely
obstructed. The initial diagnosis was tracheopathia osteo-
plastica based only on visual inspection through broncho-
scopy. Multiple biopsies from the mucosal nodules
demonstrated hyalinised, degenerated nodules of cartilage
that were associated with fibrous tissue, spotty calcifica-
tions and homogenous, eosinofilic nodules in the submu-
cosa (Fig. 3). However, amyloidosis was added to the
diagnosis because characteristic findings of amyloid were
obtained in tissue specimens stained by hematoxylin-eosin
and congo red dye, and these specimens exhibited green
birefringence under polarized microscopy (Figs. 4 and 5). 
The patient underwent extensive testing in order to rule
out systemic amyloidosis. Fat pad aspirates, a highly sensi-
tive assay for systemic amyloid deposition, did not bind to
the congo red stain. Serum or urine protein electrophoreses
failed to detect any monoclonal protein. Bone marrow
biopsy and aspirate did not identify plasmacytosis. The
case did not exhibit clonal expansion of the kappa or lambda
light chain immunoglobulin in the bone marrow through
immunohistochemical staining. Resting electrocardiograms
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Fig. 1. Computed tomography reveals irregular thickening of the tracheal wall
with sparing of the membranous posterior wall and deformed tracheal cartilage
rings without the evidence of external compression or submucosal calcification.
Fig. 2. Flexible bronchoscopic results show nodular lesions that arise from the
anterior and lateral aspects of tracheal wall narrowing its lumen. The posterior
tracheal wall was unaffected.
Fig. 3. Homogenous proteinous material with calcification under bronchus
epithelium (hematoxylin-eosin ×100).or echocardiograms did not manifest any signs of infiltra-
ting cardiac disease.
TO is a rare, benign condition and is characterized by the
presence of bony and cartilaginous nodules in the tracheal
and bronchial mucosa.
4 The entity was named “tracheopa-
thia osteoplastica” in 1910 by Aschoff.
1 Secondary syste-
mic amyloidosis (amyloid A chain; AA type) is usually
secondary to neoplastic or chronic inflammatory processes,
including multiple myeloma, rheumatoid arthritis, bronc-
hiectasis, tuberculosis, etc.
5 The current consensus is that TO
and tracheobronchial amyloidosis are not related because
each has its distinct pathology. TO does not exhibit positive
congo red staining, and tracheobronchial amyloidosis is not
associated with bony or cartilaginous formation. The con-
fusion between these two disease processes has arisen
because of similarities in their bronchoscopic appearance.
6
Localized pulmonary amyloidosis, in which amyloid
deposition is restricted to the respiratory system, is a rare
disease and occurs in three histopathologic types: tracheo-
bronchial, nodular, and diffuse parenchymal.
5 However,
respiratory tract involvement has not been a clinical feature
in over 200 patients with systemic AA amyloidosis who
were evaluated.
7 Since AA amyloidosis is a generalized
disease, it may be diagnosed in any amyloid-containing
tissue, but the most common biopsy sites are subcutaneous
fat, kidney, rectum, and liver. When amyloid is present in
small amounts, it can be easily overlooked.
8 In our case, AA
amyloidosis was confirmed histopathologically but amyloi-
dosis was not discovered in other organs except in the lung
tissue. The combination of TO and amyloidosis is rarely
reported. Leske et al.
1 reported 16 biopsy specimens that
were examined specifically for amyloidosis after congo
red staining, and only 2 of 16 specimens (13%) disclosed
both TO and amyloidosis. Therefore, amyloidosis should
be pathologically excluded in patients thought to have TO.
Bronchoscopy remains the best technique in diagnosing
TO. Bronchoscopy characteristically reveals multiple isol-
ated or confluent-appearing, submucosal, bony and cartila-
ginous nodules measuring 1 to 6 mm in diameter. The TO
lesions are dispersed more commonly in the distal two
thirds of the trachea. The nodules are projected into the
airway lumen at variable depths. The involvement of the
lobar and more peripheral bronchial tree is very rare.
1 In
bronchoscopy, hyperemic mucosal nodular lesions were
detected instead of submucosal bony and cartilaginous
nodules. These nodules completely obstructed the right
middle lobe, but the involvement of only the anterior and
lateral walls of the pulmonary system suggested TO. It has
been reported that bronchoscopic appearance alone is
sufficient enough to establish the diagnosis of TO; imaging
and biopsy specimens are usually unnecessary. However,
in cases with mucosal nodular involvement and obstruc-
tion of the lobe bronchus by nodules, biopsy should be
taken to exclude amyloidosis. In contrast to TO, tracheo-
bronchial amyloidosis typically does not spare the posterior
membranous wall. In the rare cases of TO that involves
also the posterior walls, amyloidosis may be excluded by
the pathologist using congo red dye in search of the typical
green birefringence under polarized light microscopy.
1 In
our case, posterior trachea and bronchi wall involvement
was not detected. As it is presented in our case, amyloi-
dosis can sometimes show involvement of only the anterior
and lateral walls, which confirms that diagnosis biopsy may
be needed.
Patients with tracheobronchial amyloidosis have symp-
toms that are similar to those caused by various airway
disorders.
6 TO that simulates asthma has been described
previously and should be included in the differential diag-
nosis of large airway disorders mimicking asthma.
1 Some
authors have found an association between TO and
bronchial asthma.
9,10 Vivian et al. reported that 20% of their
cases had a history of asthma-like symptoms, and 32%
whoed signs of wheezing at auscultation.
1 In our case we
also found asthmatic symptoms that lasted for 3 years. TO
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DISCUSSION
Fig. 4. Proteinous material was found to be positive with congo red stain
(histochemistry ×200).
Fig. 5. Amyloid deposition shows green birefringence under polarized
microscopy (histochemistry ×200).Gökhan Klrbas, et al.
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and amyloidosis should also be considered in elderly asth-
matic patients who are unable to be treated.
The management of patients who were diagnosed ante-
mortem with TO is typically conservative and symptomatic
because most patients do not experience serious morbidity
from the disorder.
4 The management of tracheobronchial
amyloidosis is also largely dependent upon dyspnea which
is related to bronchial obstruction and may involve inter-
mittent bronchoscopic resection, surgical resection, carbon
dioxide laser ablation, and Nd: yttrium aluminum garnet
(YAG) aser therapy. Repeated bronchoscopic intervention
is thought to be preferable and safer than open surgery.
Stenting may have a role for narrowing of the airways and
complications thereof.
7,11 No progression of the disease has
been detected in the patient after being followed up for two
years.
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